On February 11, 2026, Onconetix, Inc. signed a Share Exchange Agreement to acquire all equity interests of Realbotix Corp. in exchange for its common stock, where the Seller's ownership can range from 75% to 90% based on the company's net cash condition at closing, which must be at least $12.5 million.